Upgrade to SI Premium - Free Trial

Ingredion (INGR) PT Raised to $108 at UBS

August 5, 2026 9:19 AM
UBS analyst Joshua Spector raised the price target on Ingredion (NYSE: INGR) to $108.00 (from $104.00) while maintaining a Neutral rating.

Categories

Analyst PT Change